C07J 71/0078
Containing only sulfur
Official title: {containing only sulfur}
C07J71/0078 (Containing only sulfur) appears on 7 US grants and 3 published applications in this corpus.
Search patents in C07J- Granted patents
- 7
- Published applications
- 3
- Assignees
- 7
- Inventors
- 17
- Latest grant
- 20 Jan 2009
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 2 |
| 2005 | 0 | 1 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 0 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Sulphur analogues of 21-hydroxy-6,19-oxidoprogesterone (21OH-6OP) for treating excess of glucocorticoids20 Jan 2009US 7,479,486 B2Laboratoires Serono SA
- Sulfur analogues of 21-hydroxy-6,19-oxidoprogesterone (21OH-6OP) for treating excess of glucocorticoids30 May 2006US 7,053,228 B2Applied Research Systems ARS Holding N. V.
- 2,19-methyleneoxy and 2,19-methylenethio bridged steroids as aromatase, 19-hydroxylase inhibitors and methods of their use in the treatment of estrogen mediated disorders6 Nov 2001US 6,313,161 B1Merrell Pharmaceuticals Inc.
- 2,19-methyleneoxy and 2,19-methylenethio bridged steroids as aromatase, 19-hydroxylaser inhibitors and methods of their use in the treatment of estrogen mediated disorders13 Feb 1996US 5,491,136 AMerrell Dow Pharmaceuticals Inc.
- 2,19-methyleneoxy and 2,19-methylenethio bridged steroids as aromatase and 19-hydroxylase inhibitors24 Mar 1992US 5,099,037 AMerrell Dow Pharmaceuticals Inc.
- Sulphur analogues of 21-hydroxy-6,19-oxidoprogesterone (21OH-6OP) for treating excess of glucocorticoids6 Oct 2005US 2005/0222104 A1Applied Research Systems ARS Holding N. V.
- Sulphur analogues of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op) for treating excess of glucocorticoids12 Feb 2004US 2004/0029846 A1Applied Research Systems ARS Holding N. V.
- 17Alpha fluoroalkyl steroids, method for producing the same and pharmaceutical compositions containing said compounds5 Feb 2004US 2004/0024231 A1
Most cited
By later US patents
- Male contraceptive steroids and methods of use11US 4,297,350 AThe Upjohn Company · 1981
- 10.beta.,11.beta.-bridged steroids2US 5,093,507 ASchering Corporation · 1992
- Sulfur analogues of 21-hydroxy-6,19-oxidoprogesterone (21OH-6OP) for treating excess of glucocorticoids2US 7,053,228 B2Applied Research Systems ARS Holding N. V. · 2006
- 2,19-methyleneoxy and 2,19-methylenethio bridged steroids as aromatase, 19-hydroxylaser inhibitors and methods of their use in the treatment of estrogen mediated disorders1US 5,491,136 AMerrell Dow Pharmaceuticals Inc. · 1996